Long COVID symptoms lasted 3 years after infection for half of those infected, study finds
Nov 28, 2023
If there’s one thing we know for sure about long COVID it’s that the symptoms can linger. A new study shows just how long symptoms can persist.
Paxlovid, Lagevrio lower hospitalization, death risk in people with omicron
Sep 22, 2023
People with COVID-19 at risk for severe disease had a lower risk for death and hospitalization if they took nirmatrelvir (Paxlovid) or balapiravir (Lagevrio) compared to no treatment at all, a new study...
Developing long COVID less likely after omicron than other variants, research finds
Sep 11, 2023
The risk of developing long COVID was higher for the Alpha, Delta and wild-type variants of COVID-19 — and lower with omicron, according to new research.
FDA expected to OK second omicron booster for seniors soon
Apr 07, 2023
The Food and Drug Administration is expected to authorize a second omicron-specific booster for people 65 and older and those with comprised immune systems sometime later this month.
Study pinpoints factors than cut residents’ risk of omicron infection
Mar 30, 2023
A study of nearly 1,000 residents underscores the importance of vaccine type and number of doses in maintaining protective immunity, and reducing the risk of breakthrough infections, investigators say.
White House declares nursing home staff can now help with booster shots
Dec 19, 2022
To battle low uptake of the latest COVID-19 omicron booster shots in the US’s nursing homes, the White House has announced that facility staff can now administer shots, a big win for many, said one of...
CDC: In-hospital mortality decreased during omicron; most deaths among seniors
Sep 20, 2022
There was a 15% drop in in-hospital mortality rates between the delta and omicron periods of the pandemic. Most of the deaths that did occur were in adults aged 65 years and older.
CDC: LTC residents account for many omicron hospitalizations among the vaccinated
Sep 12, 2022
Long-term care facility residents continue to face greater risks from COVID-19 than the general public, even when they’ve been vaccinated, new data show.
Providers anticipate receiving new COVID boosters in days, following CDC panel’s approval
Sep 02, 2022
The CDC’s independent vaccine advisers voted 13-1 Thursday to recommend updated COVID-19 vaccine boosters from two manufacturers for all US adults, including seniors and others who have already had two...
FDA authorizes omicron-targeting vaccines as preferred COVID booster shots
Sep 01, 2022
The FDA has authorized new, bivalent versions of Pfizer’s and Moderna’s COVID-19 vaccines to be used as booster shots. At the same time, the original monovalent versions are no longer authorized as...